RetinalGenix Technologies (RTGN) Amortizatization of Intangibles (2025 - 2026)

RetinalGenix Technologies' (RTGN) quarterly Amortizatization of Intangibles came in at $642.0 in Q1 2026, little changed year-on-year from $641.0 in Q1 2025, and little changed quarter-over-quarter from $642.0 in Q4 2025.

RetinalGenix Technologies (RTGN) Amortizatization of Intangibles (2025 - 2026) Analysis & Trends

RetinalGenix Technologies has disclosed Amortizatization of Intangibles across 2 years of filings, most recently posting $642.0 for Q1 2026.

  • Amortizatization of Intangibles for Q1 2026 came in at $642.0, changed 0.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $2564.0 (changed N/A YoY), and the FY2025 annual result was $2563.0, up 200.12% from the prior year.
  • Amortizatization of Intangibles came in at $642.0 for Q1 2026 at RetinalGenix Technologies, roughly flat from $642.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $642.0 in Q4 2025 to a low of $640.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 422.00 Mn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 180.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 6.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 75.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 RetinalGenix Technologies - - - 642.00

Historic Data

Download Data
DateValue
Mar 31, 2026 642.00
Mar 31, 2026 642.00
Dec 31, 2025 642.00
Dec 31, 2025 642.00
Sep 30, 2025 640.00
Sep 30, 2025 640.00
Jun 30, 2025 640.00
Jun 30, 2025 640.00
Mar 31, 2025 641.00
Mar 31, 2025 641.00